secwatch.observer — SEC 8-K summary
======================================

Issuer:     CYTOKINETICS INC (CYTK)
CIK:        0001061983
Form:       8-K
Filed at:   2025-08-20T23:59:59+00:00
Accession:  0000950170-25-110368
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Cytokinetics appoints James M. Daly to Board of Directors as Class III member
-----------------------------------------------------------------------------

- James M. Daly appointed to Board effective August 19, 2025, as Class III director, term expiring at 2028 annual meeting.
- Daly also appointed to Compliance Committee; determined independent under SEC and Nasdaq rules.
- Annual director compensation: $50,000 retainer, $7,500 Compliance retainer, plus $440,000 equity grant.
- Initial option grant of 27,450 shares ($700,000 fair value) vesting over three years.
- No arrangements or transactions requiring disclosure under Item 404(a).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1061983/000095017025110368/0000950170-25-110368-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1061983/000095017025110368/cytk-20250819.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-110368

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer